EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Non-coding RNAs as regulators of the Hippo pathway in cardiac development and cardiovascular disease

Mengyang Song, He Wang, Caixia Liu, Sijie Jin, Bin Liu, Wei Sun

Frontiers in Pharmacology · 18.04.2024 · 15

DOI: 10.3389/fphar.2024.1348280 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 18.04.2024. Verfasst von Mengyang Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases pose a serious threat to human health. The onset of cardiovascular diseases involves the comprehensive effects of multiple genes and environmental factors, and multiple signaling pathways are involved in regulating the occurrence and development of cardiovascular diseases. The Hippo pathway is a highly conserved signaling pathway involved in the regulation of cell proliferation, apoptosis, and differentiation. Recently, it has been widely studied in the fields of cardiovascular disease, cancer, and cell regeneration. Non-coding RNA (ncRNAs), which are important small molecules for the regulation of gene expression in cells, can directly target genes and have diverse regulatory functions. Recent studies have found that ncRNAs interact with Hippo pathway components to regulate myocardial fibrosis, cardiomyocyte proliferation, apoptosis, and hypertrophy and play an important role in cardiovascular disease. In this review, we describe the mode of action of ncRNAs in regulating the Hippo pathway, provide new ideas for further research, and identify molecules involved in the mechanism of action of ncRNAs and the Hippo pathway as potential therapeutic targets, with the aim of finding new modes of action for the treatment and prevention of cardiovascular diseases.

Schlagwörter

Stichwörter der Autor:innen

Hippo pathwaycardiovascular developmentcardiovascular diseasecircRNAlncRNAmicroRNA

Autor:innen und Institutionen

  • Department of Cardiology, The Second Hospital of Jilin University, Changchun, China.
  • Department of Neurology, The Liaoning Province People's Hospital, Shenyang, China.

Zitieren

APA

Song, M., Wang, H., Liu, C., Jin, S., Liu, B., & Sun, W. (2024). Non-coding RNAs as regulators of the Hippo pathway in cardiac development and cardiovascular disease. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1348280

Vancouver

Song M, Wang H, Liu C, Jin S, Liu B, Sun W. Non-coding RNAs as regulators of the Hippo pathway in cardiac development and cardiovascular disease. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1348280

BibTeX
@article{Song2024,
  author = {Song, Mengyang and Wang, He and Liu, Caixia and Jin, Sijie and Liu, Bin and Sun, Wei},
  title = {Non-coding RNAs as regulators of the Hippo pathway in cardiac development and cardiovascular disease},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1348280}
}
Kostenlos starten →